The dynamics of the morphological status of the gastric mucosa in the early post-eradication period in children
DOI:
https://doi.org/10.15587/2313-8416.2016.64430Keywords:
children, gastroduodenal zone, eradication therapy, Helicobacter pylori, Lactobacillus reuteriAbstract
Helicobacter pylori (Нр) in 60–80 % of cases is the cause of forming the gastric ulcer and in у 90–95 % – the duodenum ulcer, there was also proved its connection with appearance of adenocarcinomas and gastric lymph. But elimination of Нр does not lead to the stopping of inflammatory response of mucosa. The search for the ways of control of the mucosa inflammatory response along with eradication of Нр-infection is a topical problem of children gastroenterology.
Aim of research was the study of influence of probiotic that contains Lactobacillus reuteri DSM 17938 on inflammatory changes of gastric mucosa in children with destructive forms of gastroduodenal zone pathology after successful eradication therapy.
Materials and methods of research. There were examined 98 children 8–13 years old with destructive forms of gastroduodenal pathology. The verification of diagnosis and treatment was carried out according to the actual Ukrainian MHP protocols of giving help to the children with gastroduodenal pathology. Diagnostics of Нр was carried out using histological method and detection of Нр antigen in excrements. At morphological study of mucosa bioptats there were assessed the degree of intensity of the chronic inflammatory process, its activity, presence and intensity of mucosa atrophy and metaplasia. The main group (MG) included 53 children who received the eradication therapy from the very beginning and during the month after its end received preparations that contain Lactobacillus reuteri; the control group (CG) included 45 children who received an analogous treatment but probiotics were prescribed if necessary and only at the time of taking antibiotics.
Results of research. The results of morphological studies in children from the MG demonstrated the considerably less intense inflammatory changes of mucosa than in children from the CG. Especially the degree of inflammatory process severity and activity were statistically reliably lower in MG comparing with CG. The part of patients with the symptoms of mucosa atrophy decreased more essentially in MG but the difference was not reliable.
Conclusions. After elimination of Нр in children the inflammatory changes of gastric mucosa that can be the cause of the further mucosa lesion remain stable. Prescription of probiotics that include Lactobacillus reuteri DSM 17938 resulted in decrease of inflammatory changes and it can be considered as the variant of effective and safe therapy of children in post-eradication period
References
Lyvzan, M. A., Kononov, A. V., Mozgovoj, S. Y. (2007). Techeniye khronicheskogo gastrita, assotsiirovannogo s Helicobacter pylori v posteradikatsionnom periode [The course of chronic gastritis associated with Helicobacter pylori in posteradication period]. Experimental and Clinical Pharmacology, 5, 116–123.
Hnateyko, O. Z., Lychkovska, O. L., Kulachkovska, I. Yu., Terpylyak, O. I. (2011). Rol` genetychnykh faktoriv u rozvytku skhylnosti do gastroduodenalnoyi patologiyi u ditej [The role of genetic factors in the development of predisposition to gastroduodenal pathology in children]. Pediatrics, Obstetrics and Ginecology, 6, 10–15.
Amieva, M. R., El–Omar, E. M. (2008). Host-Bacterial Interactions in Helicobacter pylori Infection. Gastroenterology, 134 (1), 306–323. doi: 10.1053/j.gastro.2007.11.009
Blaser, M. J. (1998). Helicobacters are indigenous to the human stomach: duodenal ulceration is due to changes in gastric microecology in the modern era. Gut, 43 (5), 721–727. doi: 10.1136/gut.43.5.721
Blaser, M. J., Atherton, J. C. (2004). Helicobacter pylori persistence: biology and disease. Journal of Clinical Investigation, 113 (3), 321–333. doi: 10.1172/jci20925
IARC monographs on the evaluation of carcinogenic risks to humans. Schistosomes, liver flukes and Helicobacter pylori (1994). Lyon: IARC, 61, 177–240.
Naito, S., Koga, H., Yamaguchi, A., Fujimoto, N., Hasui, Y., Kuramoto, H. et. al (2008). Prevention of Recurrence With Epirubicin and Lactobacillus Casei After Transurethral Resection of Bladder Cancer. The Journal of Urology, 179 (2), 485–490. doi: 10.1016/j.juro.2007.09.031
Sabbi, T. (2011). Short review about Helicobacter pylori infection in pediatric age: epidemiological and clinical findings, diagnosis, therapy and role of probiotics. Pediatr. Med. Chir., 33 (5-6), 221–226.
Akcam, M., Koca, T., Salman, H., Karahan, N. (2015). The effects of probiotics on treatment of Helicobacter pylori eradication in children. Saudi Medical Journal, 36 (4), 286–290. doi: 10.15537/smj.2015.3.10124
Qadri, Q., Rasool, R., Afroze, D., Naqash, S., Gulzar, G. M., Yousuf, A. et. al (2013). Study of TLR4 and IL-8 Gene Polymorphisms in H.pylori -Induced Inflammation in Gastric Cancer in an Ethnic Kashmiri Population. Immunological Investigations, 43 (4), 324–336. doi: 10.3109/08820139.2013.854378
Kim, S. S., Sung, Y. J., Park, M. K., Lim, C. H., Yang, H. J., Kim, T. H. (2008). The Change of Cyclooxygenase-2 and Inducible Nitric Oxide Synthase in the Gastric Mucosa One Year after Eradication of Helicobacter pylori. J. Gastroenterol., 52 (5), 286–292.
Moayyedi, P., Ford, A. C., Talley, N. J., Cremonini, F., Foxx-Orenstein, A. E., Brandt, L. J., Quigley, E. M. M. (2008). The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut, 59 (3), 325–332. doi: 10.1136/gut.2008.167270
Azuma, T., Ito, S., Sato, F., Yamazaki, Y., Miyaji, H., Ito, Y. et. al (1998). The role of the HLA-DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection. Cancer, 82 (6), 1013–1018. doi: 10.1002/(sici)1097-0142(19980315)82:6<1013::aid-cncr2>3.0.co;2-f
Falush, D. (2003). Traces of Human Migrations in Helicobacter pylori Populations. Science, 299 (5612), 1582–1585. doi: 10.1126/science.1080857
Yan, F. (2002). Probiotic Bacterium Prevents Cytokine-induced Apoptosis in Intestinal Epithelial Cells. Journal of Biological Chemistry, 277 (52), 50959–50965. doi: 10.1074/jbc.m207050200
Zhou, C. (2008). Lactobacilli inhibit interleukin-8 production induced by Helicobacter pylori lipopolysaccharide-activated Toll-like receptor 4. World Journal of Gastroenterology, 14 (32), 5090. doi: 10.3748/wjg.14.5090
Downloads
Published
Issue
Section
License
Copyright (c) 2016 Наталія Романівна Кеч, Олена Львівна Личковська, Олег-Роман Зиновійович Гнатейко, Ірина Юріївна Кулачковська, Вікторія Дмитрівна Семен, Людмила Ярославівна Чекан
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
